Atypical Anti-Glomerular Basement Membrane Nephritis: A Case Series From the French Nephropathology Group
Bertrand Chauveau,Jean-Baptiste Gibier,Jérôme Olagne,Antoine Morel,Selda Aydin,Stephen P. McAdoo,Nicolas Viallet,Hélène Perrochia,Emilie Pambrun,Virginie Royal,Nathalie Demoulin,Jean-Louis Kemeny,Carole Philipponnet,Alexandre Hertig,Jean-Jacques Boffa,Emmanuelle Plaisier,Camille Domenger,Isabelle Brochériou,Clément Deltombe,Jean-Paul Duong Van Huyen,David Buob,Candice Roufosse,Thomas Hellmark,Vincent Audard,Fabrice Mihout,Samih H. Nasr,Karine Renaudin,Anissa Moktefi,Marion Rabant,CFPR - French Nephropathology Group,Laurent Daniel,Laurent Doucet,Arnaud François,Viviane Gnemmi,Vincent Vuiblet
DOI: https://doi.org/10.1053/j.ajkd.2023.11.003
IF: 11.072
2024-01-01
American Journal of Kidney Diseases
Abstract:RATIONALE & OBJECTIVE: <AbstractText Label="RATIONALE &amp; OBJECTIVE" NlmCategory="OBJECTIVE">Atypical anti-glomerular basement membrane (GBM) nephritis is characterized by a bright linear immunoglobulin staining along the GBM by immunofluorescence without a diffuse crescentic glomerulonephritis nor serum anti-GBM antibodies by conventional enzyme-linked immunosorbent assay (ELISA). We characterized a series of patients with atypical anti-GBM disease.</AbstractText>STUDY DESIGN: <AbstractText Label="STUDY DESIGN" NlmCategory="METHODS">Case series.</AbstractText>SETTING & PARTICIPANTS: <AbstractText Label="SETTING &amp; PARTICIPANTS" NlmCategory="METHODS">Patients identified by the French Nephropathology Group as having atypical anti-GBM nephritis between 2003 and 2022.</AbstractText>FINDINGS: <AbstractText Label="FINDINGS" NlmCategory="RESULTS">Among 38 potential cases, 25 were included, of whom 14 (56%) were female and 23 (92%) had hematuria. The median serum creatinine at diagnosis was 150 (IQR, 102-203) μmol/L and median urine protein-creatinine ratio (UPCR) was 2.4 (IQR, 1.3-5.2) g/g. Nine patients (36%) had endocapillary proliferative glomerulonephritis (GN), 4 (16%) had mesangial proliferative GN, 4 (16%) had membranoproliferative GN, 2 (8%) had pure and focal crescentic GN, 1 (4%) had focal segmental glomerulosclerosis, and 5 had glomeruli that were unremarkable on histopathology. Nine patients (36%) had crescents, involving a median of 9% of glomeruli. Bright linear staining for IgG was seen in 22 cases (88%) and for IgA in 3 cases (12%). The 9 patients (38%) who had a monotypic staining pattern tended to be older with less proteinuria and rarely had crescents. Kidney survival rate at 1 year was 83% and did not appear to be associated with the light chain restriction.</AbstractText>LIMITATIONS: <AbstractText Label="LIMITATIONS" NlmCategory="CONCLUSIONS">Retrospective case series with a limited number of biopsies including electron microscopy.</AbstractText>CONCLUSIONS: <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Compared with typical anti-GBM disease, atypical anti-GBM nephritis frequently presents with an endocapillary or mesangial proliferative glomerulonephritis pattern and appears to have a slower disease progression. Further studies are needed to fully characterize its pathophysiology and associated clinical outcomes.</AbstractText>PLAIN-LANGUAGE SUMMARY: <AbstractText Label="PLAIN-LANGUAGE SUMMARY" NlmCategory="UNASSIGNED">Atypical anti-glomerular basement membrane (GBM) nephritis is characterized histologically by bright linear immunoglobulin staining along the GBM without diffuse crescentic glomerulonephritis or circulating anti-GBM antibodies. We report a case series of 25 atypical cases of anti-GBM nephritis in collaboration with the French Nephropathology Group. Compared with typical anti-GBM disease, we observed a slower disease progression. Patients frequently presented with heavy proteinuria and commonly had evidence of endocapillary or mesangial proliferative glomerulonephritis. About half of the patients displayed a monotypic immune staining pattern; they tended to be older, with less proteinuria, and commonly without glomerular crescents in biopsy specimens. No concomitant circulating monoclonal gammopathy was detected. Further studies are needed to fully characterize its pathophysiology and associated clinical outcomes.</AbstractText>
urology & nephrology